Literature DB >> 12675661

Effectiveness of screening in preventing blindness due to diabetic retinopathy.

C S Arun1, N Ngugi, L Lovelock, R Taylor.   

Abstract

AIMS: Diabetes remains the commonest cause of blindness in the working age population of the UK, but little information exists about the individuals who are currently losing sight from this cause. We determined the current blindness incidence (1998-2000) in Newcastle Health District and the clinical characteristics of these patients.
METHODS: Data were collected for 1998-2000 from the Royal National Institute for the Blind Liaison Office of the Newcastle Ophthalmology Department. The Ophthalmology Clinic notes on each individual were retrieved to verify clinical details, including previous eye diagnosis, dates of previous laser photocoagulation and eye surgery. The diabetes clinical records were studied to obtain information on type and duration of diabetes, blood pressure, HbA1c and other biochemical parameters. To ensure completeness of data, details of all patients registered blind attending the Newcastle Diabetic Centre were examined.
RESULTS: Twenty-eight patients were registered blind due to diabetes and 26 partially sighted during this period. The annual incidence of blindness and partial sightedness due to diabetes in the Newcastle district were 0.35 and 0.56 per 1000, respectively. The average ages in the two groups were 65.9 +/- 12.5 and 67.2 +/- 12.3 years and duration of diabetes 15.5 +/- 13.9 and 15.3 +/- 10.6 years, respectively. Proliferative retinopathy accounted for 30 and maculopathy for 24 registrations. The times from ophthalmology referral to registration were 6.2 +/- 3.5 and 4.4 +/- 3.3 years in these groups, respectively. No cases resulted from false-negative screening.
CONCLUSIONS: In Newcastle district, where the retinal screening programme has been running since 1986, the rates of blindness and partial sightedness are less than one-third of those reported in the surveys prior to 1997, confirming that objectives of the St Vincent's declarations are being achieved.

Entities:  

Mesh:

Year:  2003        PMID: 12675661     DOI: 10.1046/j.1464-5491.2003.t01-1-00899.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  10 in total

Review 1.  Clinical and Psychosocial Factors Influencing Retinal Screening Uptake Among Young Adults with Type 2 Diabetes.

Authors:  A J Lake; G Rees; J Speight
Journal:  Curr Diab Rep       Date:  2018-05-24       Impact factor: 4.810

2.  The incidence of diabetic retinopathy requiring treatment is also low in the under 90 age group.

Authors:  S J Talks; R Gupta; S Buckley
Journal:  Eye (Lond)       Date:  2016-04-15       Impact factor: 3.775

Review 3.  The English national risk-reduction programme for preservation of sight in diabetes.

Authors:  Warren Gillibrand; Deborah Broadbent; Simon Harding; Jiten Vora
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

4.  Diabetic foot disease in the United Kingdom: about time to put feet first.

Authors:  Alistair D McInnes
Journal:  J Foot Ankle Res       Date:  2012-10-11       Impact factor: 2.303

5.  Wide-field imaging and OCT vs clinical evaluation of patients referred from diabetic retinopathy screening.

Authors:  V Manjunath; V Papastavrou; D H W Steel; G Menon; R Taylor; T Peto; J Talks
Journal:  Eye (Lond)       Date:  2015-01-16       Impact factor: 3.775

6.  Evaluation of a deep learning system for the joint automated detection of diabetic retinopathy and age-related macular degeneration.

Authors:  Cristina González-Gonzalo; Verónica Sánchez-Gutiérrez; Paula Hernández-Martínez; Inés Contreras; Yara T Lechanteur; Artin Domanian; Bram van Ginneken; Clara I Sánchez
Journal:  Acta Ophthalmol       Date:  2019-11-26       Impact factor: 3.761

7.  Expanding the role of medical retina virtual clinics using multimodal ultra-widefield and optical coherence tomography imaging.

Authors:  Jing Xian Lee; Vina Manjunath; S James Talks
Journal:  Clin Ophthalmol       Date:  2018-11-15

8.  The contribution of the English NHS Diabetic Eye Screening Programme to reductions in diabetes-related blindness, comparisons within Europe, and future challenges.

Authors:  Peter H Scanlon
Journal:  Acta Diabetol       Date:  2021-04-08       Impact factor: 4.280

Review 9.  Terrestrial health applications of visual assessment technology and machine learning in spaceflight associated neuro-ocular syndrome.

Authors:  Joshua Ong; Alireza Tavakkoli; Nasif Zaman; Sharif Amit Kamran; Ethan Waisberg; Nikhil Gautam; Andrew G Lee
Journal:  NPJ Microgravity       Date:  2022-08-25       Impact factor: 4.970

10.  Perceived ethical acceptability of financial incentives to improve diabetic eye screening attendance.

Authors:  Hester Wadge; Colin Bicknell; Ivo Vlaev
Journal:  BMJ Open Diabetes Res Care       Date:  2015-11-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.